The abstract to be presented at the upcoming 2017 Cholangiocarcinoma Foundation Annual Conference describes positive findings from nonclinical studies and the Phase I clinical study with YELIVAÂÂABC294640 suggesting that YELIVAÂÂmay be an effective dru...
↧